Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0533
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease ; volume:144 ; number:1 ; day:21 ; month:5 ; year:2022 ; pages:81-106 ; date:7.2022
Acta neuropathologica ; 144, Heft 1 (21.5.2022), 81-106, 7.2022
- Creator
-
Iovino, Ludovica
Giusti, Veronica
Pischedda, Francesca
Giusto, Elena
Plotegher, Nicoletta
Marte, Antonella
Battisti, Ilaria
Iacovo, Angela Di
Marku, Algerta
Piccoli, Giovanni
Bandopadhyay, Rina
Perego, Carla
Bonifacino, Tiziana
Bonanno, Giambattista
Roseti, Cristina
Bossi, Elena
Arrigoni, Giorgio
Bubacco, Luigi
Greggio, Elisa
Hilfiker, Sabine
Civiero, Laura
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00401-022-02437-0
- URN
-
urn:nbn:de:101:1-2022081422153167814522
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Iovino, Ludovica
- Giusti, Veronica
- Pischedda, Francesca
- Giusto, Elena
- Plotegher, Nicoletta
- Marte, Antonella
- Battisti, Ilaria
- Iacovo, Angela Di
- Marku, Algerta
- Piccoli, Giovanni
- Bandopadhyay, Rina
- Perego, Carla
- Bonifacino, Tiziana
- Bonanno, Giambattista
- Roseti, Cristina
- Bossi, Elena
- Arrigoni, Giorgio
- Bubacco, Luigi
- Greggio, Elisa
- Hilfiker, Sabine
- Civiero, Laura
- SpringerLink (Online service)
Other Objects (12)
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models
LRRK2 in Parkinson's disease and dementia with Lewy bodies
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models
LRRK2 in Parkinson's disease and dementia with Lewy bodies
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models